Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: background Cushing's syndrome (CS) is associated with central adiposity, insulin resistance and impaired glucose homeostasis. Adipose tissue is thought to regulates glucose homeostasis via circulating adipokines, such as resistin, leptin and adiponectin, although their role in the insulin resistance associated with CS has not been established. design We examined the relationship between insulin resistance and adipokine levels in CS patients. We compared plasma levels of resistin, leptin and adiponectin in 10 women and four men patients with CS, with 14 health subjects matched for age, gender and body mass index. A subgroup of three women and four men with pituitary‐dependent CS were re‐examined at least 9 months after curative surgery. results CS patients had significantly more truncal fat and less lean body mass as assessed by DEXA compared to control subjects. Total cholesterol, triglycerides and insulin resistance, as calculated using the homeostasis model assessment of insulin resistance (HOMA‐R), was significantly increased in CS patients. Of the adipokines measured, only resistin was significantly different between female CS patients and female control subjects (5·05 ± 0·56 vs. 2·91 ± 0·39 µg/l, P = 0·015). Curative surgery significantly reduced total body fat and truncal fat, leptin, total and low‐density lipoprotien (LDL) cholesterol, glucose and HOMA‐R. A reduction in both resistin and adiponectin was also observed but the differences between pre‐ and post‐treatment levels did not achieve statistical significance. conclusion Here we report for the first time that resistin levels are significantly elevated in CS patients and may be important in the insulin resistance associated with glucocorticoid excess.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247
Jeong, I.-K., Oh, S.-H., Kim, B.-J., Chung, J.-H., Min, Y.-K., Lee, M.-S., Lee, M.-K., & Kim, K.-W. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00229-1 · Cited by 71
Cited by
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Anagnostis, P., Athyros, V. G., Tziomalos, K., Karagiannis, A., & Mikhailidis, D. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0370 · Cited by 613
Singh, M. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00925 · Cited by 337
Metabolic disturbances connecting obesity and depression
Hryhorczuk, C., Sharma, S., & Fulton, S. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00177 · Cited by 322
Barahona, M.-J., Sucunza, N., Resmini, E., Fernández-Real, J.-M., Ricart, W., Moreno-Navarrete, J.-M., Puig, T., Farrerons, J., & Webb, S. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0766 · Cited by 162
“Subsequently, a subgroup of these patients were reevaluated 9 months after curative surgery, when no statistical differences were observed between baseline and postsurgery adiponectin and resistin levels (17).”
BackgroundDanilowicz, K., Bruno, O. D., Manavela, M., Gomez, R. M., & Barkan, A. (2008) · Pituitary · doi:10.1007/s11102-008-0126-2 · Cited by 72
Metadata
- Authors
- Krsek, M., Silha, J. V., Jezková, J., Hána, V., Marek, J., Weiss, V., Stepán, J. J., & Murphy, L. J.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2004-02-16
- Volume
- 60
- Issue
- 3
- Pages
- 350-357
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2088902229
- Cited by
- 46
- References
- 2
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.